| |
| |
|
| Insider
Information: |
Franchini Indrani Lall |
| Relationship: |
EVP, CLO & Secretary |
| City: |
New Haven |
| State: |
CT |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
4,133 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$592,300 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
4,133 |
|
|
| Total
Value |
$592,300 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
3
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
3
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-3.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -54.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Alexion Pharmaceuticals Inc |
ALXN |
EVP, Chief Compliance ... |
2021-07-21 |
0 |
2017-06-07 |
0 |
Premium* |
|
|
Alnylam Pharmaceuticals Inc |
ALNY |
EVP, CLO & Secretary |
2024-02-28 |
4,133 |
2023-02-01 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ALNY |
Alnylam Pharmaceuticals I... |
EVP, CLO & Secretary |
• – – |
2024-02-28 |
4 |
S |
$154.54 |
$51,095 |
D/D |
(329) |
4,133 |
0 |
% |
|
| ALNY |
Alnylam Pharmaceuticals I... |
EVP, CLO & Secretary |
• – – |
2024-02-27 |
4 |
OE |
$0.00 |
$0 |
D/D |
878 |
4,462 |
0 |
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
EVP, CLO & Secretary |
• – – |
2024-02-02 |
4 |
S |
$170.01 |
$272,050 |
D/D |
(1,591) |
3,584 |
0 |
% |
|
| ALNY |
Alnylam Pharmaceuticals I... |
EVP, CLO & Secretary |
• – – |
2024-02-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,175 |
5,175 |
0 |
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
EVP, CLO & Secretary |
• – – |
2023-04-06 |
4 |
AS |
$210.00 |
$735,000 |
D/D |
(3,500) |
0 |
0 |
% |
|
| ALNY |
Alnylam Pharmaceuticals I... |
EVP, CLO & Secretary |
• – – |
2023-02-02 |
4 |
S |
$223.97 |
$378,563 |
D/D |
(1,675) |
3,500 |
0 |
% |
|
| ALNY |
Alnylam Pharmaceuticals I... |
EVP, CLO & Secretary |
• – – |
2023-02-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,175 |
5,175 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP, Chief Compliance Officer |
• – – |
2021-07-21 |
4 |
D |
$0.00 |
$0 |
D/D |
(116,075) |
0 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP, Chief Compliance Officer |
• – – |
2021-07-14 |
4 |
A |
$0.00 |
$0 |
D/D |
52,625 |
116,075 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP, Chief Compliance Officer |
• – – |
2021-06-08 |
4 |
D |
$177.00 |
$164,256 |
D/D |
(928) |
63,450 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP, Chief Compliance Officer |
• – – |
2021-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
18,033 |
64,378 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP, Chief Compliance Officer |
• – – |
2020-12-16 |
4 |
D |
$157.96 |
$3,133,610 |
D/D |
(19,838) |
46,345 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP, Chief Compliance Officer |
• – – |
2020-12-16 |
4 |
A |
$0.00 |
$0 |
D/D |
37,965 |
66,183 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP, Chief Compliance Officer |
• – – |
2020-06-08 |
4 |
AS |
$114.61 |
$785,981 |
D/D |
(6,853) |
28,218 |
0 |
% |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP, Chief Compliance Officer |
• – – |
2020-06-08 |
4 |
D |
$114.61 |
$160,798 |
D/D |
(1,403) |
35,071 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP, Chief Compliance Officer |
• – – |
2020-03-02 |
4 |
D |
$90.54 |
$114,714 |
D/D |
(1,267) |
36,474 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP, Chief Compliance Officer |
• – – |
2020-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
9,520 |
37,741 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP, Chief Compliance Officer |
• – – |
2020-02-07 |
4 |
D |
$102.97 |
$144,776 |
D/D |
(1,406) |
28,221 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP, Chief Compliance Officer |
• – – |
2019-07-01 |
4 |
AS |
$132.78 |
$597,510 |
D/D |
(4,500) |
29,627 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP, Chief Compliance Officer |
• – – |
2019-06-07 |
4 |
D |
$118.61 |
$166,528 |
D/D |
(1,404) |
34,127 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP, Chief Compliance Officer |
• – – |
2019-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
8,250 |
35,531 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP, Chief Compliance Officer |
• – – |
2019-02-28 |
4 |
D |
$132.93 |
$83,081 |
D/D |
(625) |
27,281 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP, Chief Compliance Officer |
• – – |
2019-02-07 |
4 |
D |
$119.57 |
$167,159 |
D/D |
(1,398) |
27,906 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP, Chief Compliance Officer |
• – – |
2018-11-28 |
4 |
S |
$118.13 |
$307,729 |
D/D |
(2,605) |
29,304 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP, Chief Compliance Officer |
• – – |
2018-06-08 |
4 |
S |
$118.53 |
$173,765 |
D/D |
(1,466) |
31,909 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
